Danish licensed cannabis cultivator & importer ready for rapid expansion and EU-GMP
Unique chance to acquire a turnkey, Danish licensed cannabis business with a fully-equipped cultivation and processing facility compliant with EU-GMP standards
Listing ID:
17158399530
Licence(s) Held:
• Authorization for Cultivation and Handling of Medicinal Cannabis
• Authorization for the Manufacture of Cannabis Intermediate Products (including Import, Receipt, Storage, and Distribution of Specified Products)
• Authorization for Activities Involving Euphoriant Substances
Listing Details:
Distinguished biopharmaceutical company holding licenses for cultivation, handling, storage, manufacture, storage, distribution and import of medicinal cannabis by the Danish Medicines Agency
Turnkey, operational facility with a leased area of 402m2; final approval for GACP + GMP2 area is in progress, capable of producing premium cannabis flowers
Approximately €2.2 million invested in capital and infrastructure
Development of 1 product for the Danish market currently underway, awaiting authorization approval
Projected EU-GMP license completion by 2024
Open to partial or full divestiture (90-100%); current leadership willing to stay on during transition and post-transaction
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.